MGLL Promotes Pancreatic Cancer Progression and Invasion: Potential Therapeutic Inhibition by Melatonin.
MGLL promotes pancreatic cancer progression through the P-AKT/AKT signaling pathway, and MLT may offer a novel therapeutic strategy by inhibiting MGLL expression. These findings highlight MGLL as a potential therapeutic target for PAAD.
Authors
- Zhonglue Wang
- Chenghai He
- Jin Qian (ORCID: https://orcid.org/0000-0003-2382-9850)
- Guodong Li (ORCID: https://orcid.org/0000-0003-3255-4852)
- Weimin Li (ORCID: https://orcid.org/0000-0002-9377-7219)
- Jianliang Wu (ORCID: https://orcid.org/0000-0002-4254-7261)
- Hanbo Yang (ORCID: https://orcid.org/0000-0001-6265-1851)
Institutions
- Affiliated Hospital of Hangzhou Normal University (CN)
Publication Details
- Journal
- PubMed
- Published
- 2025-01-01
- Primary Topic
- Circadian rhythm and melatonin
- Type
- article
- Field-Weighted Citation Impact
- 0.00